...
首页> 外文期刊>Revista Brasileira de Farmacognosia >Anti-candidal activity of Astragalus verus in the in vitro and in vivo guinea pig models of cutaneous and systemic candidiasis
【24h】

Anti-candidal activity of Astragalus verus in the in vitro and in vivo guinea pig models of cutaneous and systemic candidiasis

机译:黄芪对皮肤和全身念珠菌病的体外和体内豚鼠模型的抗念珠菌活性

获取原文
           

摘要

This study was design to evaluate the anti-candidal activity of Astragalus verus Olivier, Fabaceae (Av). The GC/MS analysis of essential oils of Av showed that aqueous extract contains thymol while hexadecanoic acid, 1,2-benzenedicarboxylic acid, diisooctyl ester and phytol were found as major components of methanol and acetone extracts. The aqueous extract showed anti-candidal activity in the concentration 320 mg/mL using disc diffusion method and its minimum inhibitory concentration (MIC) was 160 mg/mL. To induce cutaneous candidiasis, the dorsum of immunocompromised guinea pigs was infected with Candida albicans and animals were divided into five groups (n=5 for each): NC, received a vehicle; PC, received topical ketoconazole 2% and three other groups which received topical 10, 20 and 40% aqueous extract of Av. On ninth day postinfection, skins were cultured and colony forming unite per gram (CFU/g) skin was recorded. Systemic candidiasis was obtained by intravenous inoculation of C. albicans, 4000 CFU/g body weight. Here, animals have been divided into five groups like cutaneous candidiasis but their medications have been delivered in drinking water for ten days before induction of infection. On second day postinfection, all internal tissues were taken for determining CFU/g tissue. The aqueous extract (40%) prevented heavy burden of C. albicans in tissues and skin in oral and topical application, respectively. The results indicate that Av represents a potential source of anti-candidal drug.
机译:本研究旨在评估黄芪(Fabaceae,Av)的黄芪抗杀人活性。 GC和MS分析Av的精油表明,水提取物中含有百里酚,而十六烷酸,1,2-苯二甲酸,二异辛酯和植醇是甲醇和丙酮提取物中的主要成分。使用圆盘扩散法,水提取物在浓度为320 mg / mL时显示出抗杀虫活性,其最低抑菌浓度(MIC)为160 mg / mL。为了诱导皮肤念珠菌病,将免疫力低下的豚鼠的背部用白色念珠菌感染,并将动物分为五组(每组n = 5):NC,接受媒介物; PC,接受局部2%的酮康唑和其他三个组,分别接受局部10、20和40%Av的水提取物。感染后第9天,培养皮肤并记录菌落形成单位/克(CFU / g)。通过静脉内接种4000 CFU / g体重的白色念珠菌获得全身性念珠菌病。在这里,动物被分为皮肤念珠菌病等五类,但是在诱发感染之前,它们的药物已在饮用水中放置了十天。感染后第二天,取所有内部组织用于测定CFU / g组织。水性提取物(40%)分别预防​​口服和局部应用中白念珠菌在组织和皮肤中的沉重负担。结果表明,Av代表了抗候选药物的潜在来源。

著录项

相似文献

  • 外文文献
  • 中文文献
  • 专利
获取原文

客服邮箱:kefu@zhangqiaokeyan.com

京公网安备:11010802029741号 ICP备案号:京ICP备15016152号-6 六维联合信息科技 (北京) 有限公司©版权所有
  • 客服微信

  • 服务号